Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06768814 · ClinicalTrials.gov registry record · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
A NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 40,000
- Enrollment target
- 1
- Study location
NCT06768814 is a NA study of Opioid Use Disorder and Opioid Use that is actively recruiting participants, run by University of Washington. The registered enrollment target is 40,000 participants, above the 4,501-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (789% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06768814, a NA study of Opioid Use Disorder and Opioid Use, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 40,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the intervention participants and two comparison groups will be utilized: eligible Seattle EMS patients who opt not to go to the SASC and King County residents, outside of Seattle, who meet the same eligibility criteria. A comparative interrupted time series analysis is planned to study the main effectiveness outcomes. Seattle Fire EMS will assess, refer, and arrange transport for participants to the SASC. The SASC will offer an array of services including post-overdose monitoring, utilization of buprenorphine and methadone for the treatment opioid use disorder and opioid withdrawal, linkage to ongoing care for OUD, and provision of harm reduction services and supplies. The length of stay in the SASC will be limited to less than 24 hours. A continuous process improvement (CPI) approach will monitor and refine the intervention. Characterization of the interventions will be based upon analysis of service utilization patterns over time along with interviews and surveys with stakeholders.
Conditions Studied
Interventions
- BEHAVIORAL Sub-acute stabilization
Study Locations (1)
Washington
- Downtown Emergency Service Center's Overdose Recovery and Care Access Centers - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,000 participants |
| Start Date | 2024-12-15 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06768814
The ClinicalTrials.gov registry entry for NCT06768814 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,501-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (789% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Sub-acute stabilization is the first listed.
NCT06768814 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06768814 about?
NCT06768814 is a clinical study titled "Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data". The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the in...
What is the current status of trial NCT06768814?
This trial is currently recruiting. It is a NA study. The enrollment target is 40,000 participants. The study started on 2024-12-15. Estimated completion is 2029-05-31.
What conditions does trial NCT06768814 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use.
What interventions are being tested in trial NCT06768814?
The interventions under investigation include: Sub-acute stabilization (BEHAVIORAL).
Who is sponsoring clinical trial NCT06768814?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06768814 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.